Thursday, November 7, 2019

New GridGain for z/OS release expands in-memory computing offering to mainframe; accelerates digital transformation for enterprise clients

GridGain Systems announced GridGain for z/OS, an optimized version of the GridGain in-memory computing platform for use on the IBM z/OS operating system. GridGain for z/OS enables businesses to create solutions for efficient digital transformation of core systems as well as running analytics across their entire data estate to power real-time business processes.

GridGain for z/OS is a mainframe-optimized version of GridGain for use on the IBM z/OS operating system. GridGain for z/OS runs on IBM zIIPs (z Integrated Information Processor), the IBM processor optimized for running services such as Java on the IBM Z mainframe platform. 


GridGain is currently running trials of GridGain for z/OS with major banks and insurance companies that use IBM mainframes as the central computing platform for their core business processes. 

The IBM Z platform is used by 44 of the top 50 global banks, 4 of the top 5 airlines, and two-thirds of the Fortune 100. Across the world, IBM Z powers the most critical business systems for top enterprises, with 4.1 million core business transactions per second run on IBM Z.

IBM and GridGain will jointly present the talk “Driving efficient mainframe digital transformation leveraging GridGain/Ignite on z/OS” at the In-Memory Computing Summit North America conference on November 13-14 at the Hyatt San Francisco Airport in Silicon Valley. Mythili Venkatakrishnan, Distinguished Engineer at IBM, and Denis Magda, VP of Product Management, and Glenn Wiebe, Solution Architect, at GridGain Systems will explore how GridGain/Ignite on z/OS provides differentiated value for enterprise clients in such use cases as a coherent Financial Operational Data Store and optimized, federated real-time analytics.

The GridGain In-Memory Computing Platform provides in-memory speed and massive scalability for data-intensive applications. It requires no rip-and-replace of existing databases and can be deployed on-premises, on a public or private cloud, or on a hybrid environment. Built on a memory-centric architecture that can leverage ongoing advancements in memory and storage technologies, the solution allows companies to future-proof their applications. 


GridGain is based on the open source Apache Ignite project and offers up to a 1,000x improvement in performance versus applications built on disk-based databases. GridGain can also function as a full-featured, standalone in-memory database. GridGain supports data processing APIs including ANSI-99 SQL, key-value, compute, machine learning and more and supports ACID transactions, all at in-memory speeds.

“In-memory computing has long been an important technology for a variety of industries, including financial services, transportation and logistics, ecommerce, healthcare, and telecommunications,” said Matt Aslett, research vice president at 451 Research. “However, running in-memory computing platforms on mainframe systems is a new development. Given the penetration and ongoing importance of mainframe computing in a range of Fortune 100 companies, GridGain for z/OS opens up a new addressable market opportunity for in-memory computing.”

“GridGain on z/OS represents another leap forward for enterprise digital transformations based on in-memory computing technology,” said said Abe Kleinfeld, president & CEO of GridGain Systems. “We anticipate that GridGain for z/OS will find interest across a broad range of industries that rely on the Z platform for core applications. Deploying our in-memory platform on IBM z/OS to power real-time business is a natural evolution of in-memory adoption that began with distributed commodity servers and has now expanded to the core of large enterprises – the IBM mainframe.”

No comments:

Post a Comment

Masimo secures FDA clearance for neonatal RD SET Pulse Oximetry sensors with improved accuracy specifications

Masimo announced that RD SET sensors with Masimo Measure-through Motion and Low Perfusion SET pulse oximetry have received FDA clearance ...